| 4623- | Bor, | Proteomic insights into the anti-cancer mechanisms of boron-based compounds in prostate cancer |
| - | Review, | Pca, | NA |
| 4622- | Bor, | Boron Level in the Prostate of the Normal Human: A Systematic Review |
| - | Review, | BPH, | NA |
| 696- | Bor, | Nothing Boring About Boron |
| - | Review, | Var, | NA |
| 697- | Bor, | Boron-containing compounds as preventive and chemotherapeutic agents for cancer |
| - | Review, | NA, | NA |
| 698- | Bor, | Boron deprivation decreases liver S-adenosylmethionine and spermidine and increases plasma homocysteine and cysteine in rats |
| - | in-vitro, | NA, | NA |
| 699- | Bor, | Boric Acid Alleviates Gastric Ulcer by Regulating Oxidative Stress and Inflammation-Related Multiple Signaling Pathways |
| - | in-vivo, | NA, | NA |
| 700- | Bor, | Diadenosine phosphates and S-adenosylmethionine: novel boron binding biomolecules detected by capillary electrophoresis |
| - | Analysis, | NA, | NA |
| 701- | Bor, | Dietary boron intake and prostate cancer risk |
| - | Analysis, | NA, | NA |
| 702- | Bor, | GEN, | SeMet, | Rad, | Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States) |
| - | Analysis, | NA, | NA |
| 703- | Bor, | Boron intake and prostate cancer risk |
| - | Analysis, | NA, | NA |
| 704- | Bor, | Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid |
| - | in-vitro, | Pca, | NA |
| 705- | Bor, | Boric acid inhibits human prostate cancer cell proliferation |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | LNCaP |
| 754- | Bor, | HRT, | Dietary Boron and Hormone Replacement Therapy as Risk Factors for Lung Cancer in Women |
| - | Analysis, | NA, | NA |
| 739- | Bor, | Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | HMC3 |
| 740- | Bor, | Anti-cancer effect of boron derivatives on small-cell lung cancer |
| - | in-vitro, | Lung, | DMS114 | - | in-vitro, | Nor, | MRC-5 |
| 741- | Bor, | Boron Derivatives Inhibit the Proliferation of Breast Cancer Cells and Affect Tumor-Specific T Cell Activity In Vitro by Distinct Mechanisms |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
| 742- | Bor, | In Vitro Effects of Boric Acid on Cell Cycle, Apoptosis, and miRNAs in Medullary Thyroid Cancer Cells |
| - | in-vitro, | Thyroid, | NA |
| 743- | Bor, | Boric Acid (Boron) Attenuates AOM-Induced Colorectal Cancer in Rats by Augmentation of Apoptotic and Antioxidant Mechanisms |
| - | in-vitro, | CRC, | NA |
| 744- | Bor, | Borax affects cellular viability by inducing ER stress in hepatocellular carcinoma cells by targeting SLC12A5 |
| - | in-vitro, | HCC, | HepG2 | - | in-vitro, | Nor, | HL7702 |
| 745- | Bor, | Investigation of cytotoxic antiproliferative and antiapoptotic effects of nanosized boron phosphate filled sodium alginate composite on glioblastoma cancer cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | L929 | - | in-vitro, | GBM, | T98G |
| 746- | Bor, | Organoboronic acids/esters as effective drug and prodrug candidates in cancer treatments: challenge and hope |
| - | Review, | NA, | NA |
| 747- | Bor, | Growing Evidence for Human Health Benefits of Boron |
| - | Review, | NA, | NA |
| 748- | Bor, | A Study on the Anticarcinogenic Effects of Calcium Fructoborate |
| - | in-vitro, | BC, | MDA-MB-231 |
| 749- | Bor, | Comparative effects of boric acid and calcium fructoborate on breast cancer cells |
| 750- | Bor, | Calcium fructoborate regulate colon cancer (Caco-2) cytotoxicity through modulation of apoptosis |
| - | in-vitro, | CRC, | Caco-2 |
| 751- | Bor, | 5-FU, | Cytotoxic and Apoptotic Effects of the Combination of Borax (Sodium Tetraborate) and 5-Fluorouracil on DLD-1 Human Colorectal Adenocarcinoma Cell Line |
| - | in-vitro, | CRC, | DLD1 |
| 752- | Bor, | The Potential Role of Boron in the Modulation of Gut Microbiota Composition: An In Vivo Pilot Study |
| 753- | Bor, | Boron Intake and decreased risk of mortality in kidney transplant recipients |
| 707- | Bor, | Cytotoxic and apoptotic effects of boron compounds on leukemia cell line |
| - | in-vitro, | AML, | HL-60 |
| 755- | Bor, | https://aacrjournals.org/cancerres/article/67/9_Supplement/4220/535557/Boric-acid-induces-apoptosis-in-both-prostate-and |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | PC, | PC3 |
| 756- | Bor, | Evaluation of Boric Acid Treatment on microRNA‐127‐5p and Metastasis Genes Orchestration of Breast Cancer Stem Cells |
| - | in-vitro, | BC, | MCF-7 |
| 757- | Bor, | Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Nor, | RWPE-1 |
| 758- | Bor, | Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines |
| - | Human, | NA, | NA |
| 759- | Bor, | The nutritional and metabolic effects of boron in humans and animals |
| - | in-vivo, | NA, | NA |
| 760- | Bor, | Therapeutic Efficacy of Boric Acid Treatment on Brain Tissue and Cognitive Functions in Rats with Experimental Alzheimer’s Disease |
| - | in-vivo, | AD, | NA |
| 761- | Bor, | Prevalence of Prostate Cancer in High Boron-Exposed Population: A Community-Based Study |
| - | Study, | BPH, | NA |
| 762- | Bor, | Mechanism of boric acid cytotoxicity in breast cancer cell lines |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | ZR-75-1 |
| 763- | Bor, | Investigation of The Apoptotic and Antiproliferative Effects of Boron on CCL-233 Human Colon Cancer Cells |
| - | in-vitro, | Colon, | CCl233 |
| 764- | Bor, | Effect of Tumor Microenvironment on Selective Uptake of Boric Acid in HepG2 Human Hepatoma Cells |
| - | in-vitro, | Liver, | HepG2 |
| 765- | Bor, | High concentrations of boric acid induce autophagy in cancer cell lines |
| 766- | Bor, | In vitro effects of boric acid on human liver hepatoma cell line (HepG2) at the half-maximal inhibitory concentration |
| - | in-vitro, | Liver, | HepG2 |
| 767- | Bor, | Boric acid induces cytoplasmic stress granule formation, eIF2α phosphorylation, and ATF4 in prostate DU-145 cells |
| - | in-vitro, | Pca, | DU145 |
| 768- | Bor, | In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells |
| - | in-vitro, | BC, | 4T1 |
| 706- | Bor, | Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice |
| - | in-vivo, | Pca, | LNCaP |
| 737- | Bor, | Boric Acid Activation of eIF2α and Nrf2 Is PERK Dependent: a Mechanism that Explains How Boron Prevents DNA Damage and Enhances Antioxidant Statu |
| - | in-vitro, | Pca, | DU145 |
| 738- | Bor, | Borax induces ferroptosis of glioblastoma by targeting HSPA5/NRF2/GPx4/GSH pathways |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | A172 | - | in-vitro, | Nor, | SVGp12 |
| 708- | Bor, | Boron containing compounds as protease inhibitors |
| 709- | Bor, | Cellular changes in boric acid-treated DU-145 prostate cancer cells |
| - | in-vitro, | Pca, | DU145 |
| 710- | Bor, | Boric acid inhibits stored Ca2+ release in DU-145 prostate cancer cells |
| - | in-vitro, | Pca, | DU145 |
| 711- | Bor, | Receptor Activated Ca2+ Release Is Inhibited by Boric Acid in Prostate Cancer Cells |
| - | in-vitro, | Pca, | DU145 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid